These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22755031)

  • 1. Physicochemical characterization, photo-stability and cytotoxicity of coenzyme Q10-loading nanostructured lipid carrier.
    Wang J; Wang H; Zhou X; Tang Z; Liu G; Liu G; Xia Q
    J Nanosci Nanotechnol; 2012 Mar; 12(3):2136-48. PubMed ID: 22755031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.
    Wang J; Tang J; Zhou X; Xia Q
    Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The advantages of a novel CoQ10 delivery system in skin photo-protection.
    Yue Y; Zhou H; Liu G; Li Y; Yan Z; Duan M
    Int J Pharm; 2010 Jun; 392(1-2):57-63. PubMed ID: 20302925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10).
    Nanjwade BK; Kadam VT; Manvi FV
    J Biomed Nanotechnol; 2013 Mar; 9(3):450-60. PubMed ID: 23621001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
    Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
    Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity.
    Saedi A; Rostamizadeh K; Parsa M; Dalali N; Ahmadi N
    Chem Phys Lipids; 2018 Nov; 216():65-72. PubMed ID: 30219661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, Characterization, and Molecular Dynamic Simulation of Novel Coenzyme Q10 Loaded Nanostructured Lipid Carriers.
    Atapour-Mashhad H; Nejabat M; Hadizadeh F; Hoseinsalari A; Golmohammadzadeh S
    Curr Pharm Des; 2023; 29(27):2177-2190. PubMed ID: 37694784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-small NLC for improved dermal delivery of coenyzme Q10.
    Schwarz JC; Baisaeng N; Hoppel M; Löw M; Keck CM; Valenta C
    Int J Pharm; 2013 Apr; 447(1-2):213-7. PubMed ID: 23438979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, characterization, molecular docking, and
    Aryani NLD; Siswodihardjo S; Soeratri W; Sari NFI
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):517-525. PubMed ID: 34214318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions.
    Brugè F; Damiani E; Puglia C; Offerta A; Armeni T; Littarru GP; Tiano L
    Int J Pharm; 2013 Oct; 455(1-2):348-56. PubMed ID: 23850626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).
    Teeranachaideekul V; Morakul B; Boonme P; Pornputtapitak W; Junyaprasert V
    J Oleo Sci; 2020; 69(12):1627-1639. PubMed ID: 33268665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model.
    Shoviantari F; Erawati T; Soeratri W
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31860468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
    Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
    Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of solid lipid's structure on nanostructured lipid carriers encapsulated with sun filter: characterisation, photo-stability and in vitro release.
    Wang K; Zhang QJ; Miao YL; Luo SQ; Wang HC; Zhang WP
    J Microencapsul; 2017 Feb; 34(1):104-110. PubMed ID: 28152634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations.
    Yang X; Zhao L; Almasy L; Garamus VM; Zou A; Willumeit R; Fan S
    Int J Pharm; 2013 Jun; 450(1-2):225-34. PubMed ID: 23608200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro.
    Wang J; Xia Q
    Drug Deliv; 2014 Aug; 21(5):328-41. PubMed ID: 24144220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.